William Blair Has Optimistic Outlook of SLP FY2025 Earnings

Simulations Plus, Inc. (NASDAQ:SLP - Free Report) - Equities researchers at William Blair lifted their FY2025 earnings per share (EPS) estimates for shares of Simulations Plus in a report released on Wednesday, July 16th. William Blair analyst M. Smock now anticipates that the technology company will post earnings per share of $0.97 for the year, up from their previous estimate of $0.90. William Blair has a "Outperform" rating on the stock. The consensus estimate for Simulations Plus' current full-year earnings is $1.09 per share. William Blair also issued estimates for Simulations Plus' Q4 2025 earnings at $0.04 EPS, Q2 2026 earnings at $0.30 EPS, Q3 2026 earnings at $0.30 EPS and Q4 2026 earnings at $0.08 EPS.

Several other equities analysts have also recently commented on the company. KeyCorp cut Simulations Plus from an "overweight" rating to a "sector weight" rating in a research report on Tuesday, July 15th. Craig Hallum reduced their target price on Simulations Plus from $45.00 to $36.00 and set a "buy" rating for the company in a research report on Friday, June 13th. Stephens reduced their target price on Simulations Plus from $28.00 to $20.00 and set an "overweight" rating for the company in a research report on Tuesday, July 15th. BTIG Research dropped their price objective on shares of Simulations Plus from $41.00 to $25.00 and set a "buy" rating for the company in a report on Monday, July 7th. Finally, JMP Securities reaffirmed a "market perform" rating on shares of Simulations Plus in a report on Wednesday, June 18th. Three analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average price target of $26.50.

Simulations Plus Stock Up 3.3%

SLP traded up $0.42 during trading on Friday, reaching $12.88. 310,881 shares of the company were exchanged, compared to its average volume of 307,157. Simulations Plus has a 12-month low of $12.39 and a 12-month high of $42.11. The company's 50-day moving average is $23.10 and its two-hundred day moving average is $27.87. The company has a market cap of $259.17 million, a price-to-earnings ratio of -4.09 and a beta of 0.83.

Simulations Plus (NASDAQ:SLP - Get Free Report) last issued its quarterly earnings data on Monday, July 14th. The technology company reported $0.45 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.26 by $0.19. The business had revenue of $20.36 million for the quarter, compared to analysts' expectations of $22.83 million. Simulations Plus had a positive return on equity of 11.62% and a negative net margin of 78.63%. The firm's quarterly revenue was up 9.8% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.27 EPS.

Insiders Place Their Bets

In other Simulations Plus news, Director Walter S. Woltosz sold 20,000 shares of the firm's stock in a transaction dated Thursday, May 1st. The stock was sold at an average price of $33.51, for a total transaction of $670,200.00. Following the sale, the director owned 3,344,157 shares in the company, valued at $112,062,701.07. This trade represents a 0.59% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. 19.40% of the stock is owned by insiders.

Institutional Trading of Simulations Plus

Several institutional investors have recently added to or reduced their stakes in SLP. Jones Financial Companies Lllp boosted its position in Simulations Plus by 53.6% during the fourth quarter. Jones Financial Companies Lllp now owns 1,223 shares of the technology company's stock valued at $34,000 after buying an additional 427 shares during the period. Charles Schwab Investment Management Inc. boosted its position in Simulations Plus by 4.7% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 143,253 shares of the technology company's stock valued at $3,995,000 after buying an additional 6,418 shares during the period. Proficio Capital Partners LLC purchased a new stake in Simulations Plus during the fourth quarter valued at about $719,000. AlphaQuest LLC boosted its position in Simulations Plus by 502.9% during the fourth quarter. AlphaQuest LLC now owns 2,689 shares of the technology company's stock valued at $75,000 after buying an additional 2,243 shares during the period. Finally, Natixis Advisors LLC purchased a new stake in Simulations Plus during the fourth quarter valued at about $288,000. 78.08% of the stock is currently owned by hedge funds and other institutional investors.

Simulations Plus Company Profile

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.